437 related articles for article (PubMed ID: 15675205)
21. Procalcitonin levels predict infectious complications and response to treatment in patients undergoing cytoreductive surgery for peritoneal malignancy.
Saeed K; Dale AP; Leung E; Cusack T; Mohamed F; Lockyer G; Arnaudov S; Wade A; Moran B; Lewis G; Dryden M; Cecil T; Cepeda JA
Eur J Surg Oncol; 2016 Feb; 42(2):234-43. PubMed ID: 26560024
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of procalcitonin levels in patients with systemic inflammatory response syndrome as the diagnosis of infection and the severity of illness].
Endo S; Kasai T; Inada K
Kansenshogaku Zasshi; 1999 Mar; 73(3):197-204. PubMed ID: 10222664
[TBL] [Abstract][Full Text] [Related]
23. Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions?
Iapichino G; Marzorati S; Umbrello M; Baccalini R; Barassi A; Cainarca M; Colombo Pavini F; Mantovani E; Mauri A; Moroni B; Noto A; Melzi D'Eril GV; Langer M
Minerva Anestesiol; 2010 Oct; 76(10):814-23. PubMed ID: 20935617
[TBL] [Abstract][Full Text] [Related]
24. [Diagnostic value of serum procalcitonin for infection in the immunocompromised critically ill patients with suspected infection].
Yu X; Ma X; Ai Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jun; 27(6):477-83. PubMed ID: 26049187
[TBL] [Abstract][Full Text] [Related]
25. [Clinical verification of serum procalcitonin measurement in sepsis].
Nakadai H; Yoshizawa S; Miyamoto H; Ikeda Y; Akizuki S; Ohnishi A
Rinsho Byori; 2013 Sep; 61(9):781-6. PubMed ID: 24369589
[TBL] [Abstract][Full Text] [Related]
26. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients.
Wanner GA; Keel M; Steckholzer U; Beier W; Stocker R; Ertel W
Crit Care Med; 2000 Apr; 28(4):950-7. PubMed ID: 10809265
[TBL] [Abstract][Full Text] [Related]
27. Procalcitonin, C-reactive protein and serum lactate dehydrogenase in the diagnosis of bacterial sepsis, SIRS and systemic candidiasis.
Miglietta F; Faneschi ML; Lobreglio G; Palumbo C; Rizzo A; Cucurachi M; Portaccio G; Guerra F; Pizzolante M
Infez Med; 2015 Sep; 23(3):230-7. PubMed ID: 26397291
[TBL] [Abstract][Full Text] [Related]
28. Use of a Combination Biomarker Algorithm To Identify Medical Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection.
Han JH; Nachamkin I; Coffin SE; Gerber JS; Fuchs B; Garrigan C; Han X; Bilker WB; Wise J; Tolomeo P; Lautenbach E;
Antimicrob Agents Chemother; 2015 Oct; 59(10):6494-500. PubMed ID: 26239984
[TBL] [Abstract][Full Text] [Related]
29. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis.
Castelli GP; Pognani C; Cita M; Stuani A; Sgarbi L; Paladini R
Minerva Anestesiol; 2006; 72(1-2):69-80. PubMed ID: 16407808
[TBL] [Abstract][Full Text] [Related]
30. [Diagnostic and prognostic value of procalcitonin and common inflammatory markers combining SOFA score in patients with sepsis in early stage].
Xing YB; Dai LM; Zhao ZH; Li ZW; Li C
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Jan; 20(1):23-8. PubMed ID: 18199396
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of procalcitonin and some inflammatory parameters in septic patients.
Tasabehji WR; Al-Quobaili FA; Al-Daher NA
Saudi Med J; 2008 Apr; 29(4):520-5. PubMed ID: 18382791
[TBL] [Abstract][Full Text] [Related]
32. Clinical utility of procalcitonin as a marker of sepsis: a potential predictor of causative pathogens.
Nakajima A; Yazawa J; Sugiki D; Mizuguchi M; Sagara H; Fujisiro M; Shibazaki M; Hitani A; To M; Haruki K
Intern Med; 2014; 53(14):1497-503. PubMed ID: 25030560
[TBL] [Abstract][Full Text] [Related]
33. Discriminative power of inflammatory markers for prediction of tumor necrosis factor-alpha and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points.
Oberhoffer M; Russwurm S; Bredle D; Chatzinicolaou K; Reinhart K
Intensive Care Med; 2000 Mar; 26 Suppl 2():S170-4. PubMed ID: 18470714
[TBL] [Abstract][Full Text] [Related]
34. [Usefulness of procalcitonin upon admission to intensive care in the diagnosis and prognosis of sepsis].
Moretti D; Ramírez MM; Settecase CJ; Bagilet DH; Quaglino MB
Med Intensiva; 2013 Apr; 37(3):156-62. PubMed ID: 22658964
[TBL] [Abstract][Full Text] [Related]
35. [Procalcitonin as a diagnostic marker in systemic inflammatory response syndrome (SIRS) and sepsis].
Hryckiewicz K; Juszczyk J; Samet A; Arłukowicz E; Sledzińska A; Bolewska B
Przegl Epidemiol; 2006; 60(1):7-15. PubMed ID: 16758733
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department].
Zhao Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):153-8. PubMed ID: 24598287
[TBL] [Abstract][Full Text] [Related]
37. Serum procalcitonin and interleukin-6 levels may help to differentiate systemic inflammatory response of infectious and non-infectious origin.
Du B; Pan J; Chen D; Li Y
Chin Med J (Engl); 2003 Apr; 116(4):538-42. PubMed ID: 12875718
[TBL] [Abstract][Full Text] [Related]
38. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study.
Anand D; Das S; Bhargava S; Srivastava LM; Garg A; Tyagi N; Taneja S; Ray S
J Crit Care; 2015 Feb; 30(1):218.e7-12. PubMed ID: 25263339
[TBL] [Abstract][Full Text] [Related]
39. Use of procalcitonin as a biomarker for sepsis in pediatric burns.
Oncul U; Dalgıç N; Demir M; Karadeniz P; Karadağ ÇA
Eur J Pediatr; 2023 Apr; 182(4):1561-1567. PubMed ID: 36752894
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
Sridharan P; Chamberlain RS
Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
